Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...

Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, this week saw the biggest spike in Covid case numbers since records began in ...

Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

Add Yahoo as a preferred source to see more of our stories on Google. High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent ...

Record numbers of people in England and Wales are testing positive for covid-19. Here’s what you need to know about how lateral flow tests work, why symptoms may linger even if a person is no longer ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

Polymerase chain reaction (PCR) tests were the first available for spotting the coronavirus. They work by detecting the virus’s genetic material, and are very accurate. Then came rapid tests, also ...

The recently FDA-authorized alpha-defensin lateral flow test is a highly accurate, ten-minute test for diagnosis of periprosthetic joint infection (PJI) - a serious and costly complication of total ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...